News • Checkpoint inhibitor immunotherapy efficacy
AI tool uses routine blood tests to predict cancer immunotherapy response
Researchers have developed an AI-based model to better predict whether cancer patients will benefit from immunotherapy — using only routine blood tests and clinical data.